What does this video actually claim?
Live Well Collective suggests that when hormone replacement therapy (HRT) doesn't work, most providers just increase the dose. Instead, they claim to investigate "hidden blockers" like flat cortisol patterns, elevated sex hormone-binding globulin (SHBG), poor thyroid conversion, and delivery method issues.
The video positions their practice as taking a deeper approach than typical providers. They're targeting women who have normal lab values but still experience symptoms like poor energy, sleep problems, weight issues, or mood changes despite HRT treatment.
Is their approach scientifically sound?
Some of their concerns have legitimate basis in endocrine research. SHBG levels do significantly affect free hormone availability, with studies showing that SHBG can bind 60-80% of circulating testosterone and estradiol (Hammond et al., Journal of Steroid Biochemistry, 2016).
The cortisol-hormone interaction claim has support too. Research by Pasquali et al. (Clinical Endocrinology, 2019) demonstrated that dysregulated cortisol patterns can interfere with sex hormone receptor sensitivity. However, measuring "flat cortisol patterns" isn't standard clinical practice.
Their thyroid conversion point about reverse T3 is where things get questionable. Multiple studies, including Jonklaas et al. (Thyroid, 2018), found that reverse T3 levels don't correlate well with clinical symptoms or treatment outcomes.
What did they get wrong about HRT optimization?
The biggest issue is their claim that "most providers" just increase doses when HRT doesn't work. That's not accurate clinical practice.
Standard HRT protocols already include checking SHBG, thyroid function, and cortisol levels before dose adjustments. The Endocrine Society's 2017 guidelines specifically recommend evaluating these factors when patients don't respond to initial treatment.
They also oversimplify HRT "failure." Research by Stuenkel et al. (Journal of Clinical Endocrinology, 2020) showed that 15-25% of women need dose or delivery method adjustments, but this usually reflects normal individual variation, not "hidden blockers."
Should you worry about these "blockers"?
Some of their testing makes sense, but not all of it. SHBG testing is standard when HRT isn't working effectively, and most competent providers already check this.
Cortisol pattern testing can be useful, but the "flat pattern" description is vague. Salivary cortisol testing has high variability, with studies showing 20-30% day-to-day variation in healthy individuals (Hellhammer et al., Psychoneuroendocrinology, 2019).
Skip the reverse T3 testing unless you have clear hypothyroid symptoms despite normal TSH and free T4. The American Thyroid Association doesn't recommend routine reverse T3 measurement because it rarely changes treatment decisions.
What should you actually know about HRT optimization?
Good HRT management already includes most of what they're suggesting. If your current provider isn't checking SHBG, thyroid function, and basic metabolic markers when HRT isn't working, find a better provider.
The delivery method point is valid. Transdermal estradiol produces more stable levels than oral forms and doesn't increase SHBG as much, according to data from the Women's Health Initiative follow-up studies.
But don't assume your HRT is "failing" if you still have some symptoms. Even well-managed HRT doesn't solve every health issue, and expecting it to fix energy, weight, mood, and sleep problems might be unrealistic.